Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
33.62
-0.78 (-2.27%)
Jun 1, 2026, 4:08 PM HKT
Market Cap7.04B +53.3%
Revenue (ttm)1.19B +25.1%
Net Income229.49M +14.0%
EPS1.40 +14.2%
Shares Out 209.45M
PE Ratio24.06
Forward PEn/a
Dividend0.26 (0.76%)
Ex-Dividend DateJun 3, 2026
Volume163,600
Open34.54
Previous Close34.40
Day's Range33.42 - 34.60
52-Week Range20.10 - 41.40
Beta0.07
Analystsn/a
Price Targetn/a
Earnings DateMar 27, 2026

About HKG:1501

Shanghai INT Medical Instruments Co., Ltd., together with its subsidiaries, engages in the research and development, manufacture, and sale of cardiovascular interventional medical devices in Mainland China, Europe, the United States, and internationally. It offers transradial and femoral pressure bandage, hydrophilic guidewire, pressure Y-connector set, PTFE guidewire, PTCA balloon dilatation catheter, noncompliant balloon dilatation catheter, compression femoral artery tourniquet, vascular sheaths for single use, push-to-thread balloon dilatio... [Read more]

Sector Healthcare
Founded 2006
Employees 2,088
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1501
Full Company Profile

Financial Performance

In 2025, HKG:1501's revenue was 1.07 billion, an increase of 25.06% compared to the previous year's 851.95 million. Earnings were 206.23 million, an increase of 13.99%.

Financial numbers in CNY Financial Statements